| Literature DB >> 31569501 |
Yu Ji1,2,3, Hongyan Hao4,5, Kurt Reynolds6,7,8, Moira McMahon9,10, Chengji J Zhou11,12,13.
Abstract
Neural crest (NC) cells are a temporary population of multipotent stem cells that generate a diverse array of cell types, including craniofacial bone and cartilage, smooth muscle cells, melanocytes, and peripheral neurons and glia during embryonic development. Defective neural crest development can cause severe and common structural birth defects, such as craniofacial anomalies and congenital heart disease. In the early vertebrate embryos, NC cells emerge from the dorsal edge of the neural tube during neurulation and then migrate extensively throughout the anterior-posterior body axis to generate numerous derivatives. Wnt signaling plays essential roles in embryonic development and cancer. This review summarizes current understanding of Wnt signaling in NC cell induction, delamination, migration, multipotency, and fate determination, as well as in NC-derived cancers.Entities:
Keywords: Wnt; neural crest stem cells; neural crest-derived cancer
Mesh:
Year: 2019 PMID: 31569501 PMCID: PMC6829301 DOI: 10.3390/cells8101173
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1Anatomically distinct neural crest cell populations and their major derivates. Schematic lateral view of a mouse embryo at embryonic day 9.5 shows the cranial (green), vagal (azure), trunk (purple), and sacral (ruby) neural crest cells and their major derivatives. Vagal segment includes cardiac neural crest (indigo).
Figure 2Wnt signaling regulates neural plate border (NPB) induction by regulating NPB specifiers. (A) NPB induction begins during gastrulation and is regulated by both canonical (orange) and non-canonical (blue) Wnts secreted from NPB and paraxial mesoderm. (B) Key components and possible interactions between Wnt signaling and NPB specifiers. NNE, non-neural ectoderm; NP, neural plate.
Figure 3Wnt signaling induces neural crest cells by regulating NC specifiers. (A) NC is induced from the neural plate border at the end of gastrulation (zebrafish and Xenopus) or the beginning of neurulation (chick and mouse). This process is regulated by both canonical (orange) and non-canonical (blue) Wnts secreted from NPB, adjacent NNE, and paraxial mesoderm. (B) Key components and possible interactions between Wnt signaling and NC specifiers. NC, neural crest; NNE, non-neural ectoderm; NT, neural tube.
Experimental findings of Wnt signaling molecules, modulators, and effectors in vertebrate neural crest induction and specification. (cKO, conditional knockout; GOF, gain of function; KO, knockout; LOF, loss of function; MO; morpholino).
| Molecule | Role in Wnt Signaling | Experimental Approach | Function | Region | Species | Phenotype | Reference |
|---|---|---|---|---|---|---|---|
| ADAM13 | upregulates canonical Wnt signaling by cleaving class B Ephrins | MO | LOF | cranial |
| defective NC induction (Snai2, Sox9, Foxd3) and head cartilage | [ |
| ADAM19 | upregulates canonical Wnt signaling by stabilizing ADAM13 | MO | LOF | cranial |
| defective NC induction (Snai2, Sox9, Foxd3) and head cartilage | [ |
| Aldh1a2 | delay Wnt3a and Wnt8a expression | KO | LOF | trunk | mouse | diminished NPB specification (Msx1, Pax3) | [ |
| Apoc1 | downstream effector of canonical Wnt signaling | MO | LOF | cranial |
| defective NPB induction (Msx1, Pax3, Zic1), eyes and head deformation | [ |
| Awp1 | stabilizes Ctnnb1 | MO | LOF | cranial |
| defective NPB induction (Msx1, Pax3), pigmentation and craniofacial cartilage | [ |
| Axud1 | downstream effector of canonical Wnt signaling | MO, dominant-negative construct | LOF | trunk | chick | defective NC inductions (Foxd3, Sox9, Sox10, Ets1) | [ |
| Cdh11 | competitive binding with Ctnnb1 to repress Wnt/Ctnnb1 signaling | MO | LOF | cranial |
| increased Wnt/Ctnnb1 signaling and NC induction (Sox10, Ap2) | [ |
| Ctnnb1 | coactivator for Tcf/Lef1 transcription factor | RNA injection, MO | GOF; LOF | cranial |
| expanded (GOF) or diminished (LOF) NC induction (Snai2, Twist) | [ |
| Daam1 | mediator of non-canonical Wnt signaling and actin polymerization | MO, mutations | LOF | cranial |
| defective NC induction (Twist, Sox8, Snai2, Sox10) | [ |
| Dkk1 | antagonist of canonical Wnt signaling | blocking antibody, Dkk1-null mouse | LOF | cranial | NC generated in the anterior neural fold, expanded cranial cartilages | [ | |
| Dkk2 | positive regulator of canonical Wnt signaling independent of Gsk3b | MO | LOF | cranial |
| defective NC induction (Snai2, Twist1, Sox10), reduced craniofacial cartilages | [ |
| Dvl (Dsh) | canonical and non-canonical Wnt signaling | mutants (dd1, dd2) | LOF | cranial |
| repressed NC induction (Snai2) | [ |
| PCP signaling | PCP mutants: ΔN-Dsh, Dsh-DEP+ | GOF, LOF | cranial |
| expanded (GOF) or decreased (LOF) NC induction (Foxd3, Sox8, Snai2) | [ | |
| Fgf8a | induce Wnt8 in the paraxial mesoderm | MO, RNA injection | LOF, GOF | cranial |
| defective (LOF) NPB induction (Pax3), induced (GOF) NC in anterior neural plate | [ |
| Fzd3 | receptor for Wnt1 | RNA injection, MO | GOF, LOF | cranial |
| Induced (GOF) or diminished (LOF) NC induction (Snai, Twist) | [ |
| Fzd7 | receptor in canonical Wnt/Ctnnb1 signaling | MO | LOF | cranial |
| inhibited NC induction, loss of pigment cells | [ |
| Gbx2 | direct target of canonical Wnt signaling | MO, RNA injection | LOF, GOF | cranial |
| diminished (LOF) or rescued (GOF) NPB specifiers (Pax3, Msx1) | [ |
| Gsk3b | phosphorylation and degradation of Ctnnb1 | RNA Injections | GOF | cranial |
| increased NC induction (Krox20, Ap2, Snai2) | [ |
| Hes3 | inhibition of Wnt/Ctnnb1 signaling | expression constructs | GOF | cranial, trunk |
| blocked NC specifiers (Snai2, Sox10), supernumerary pigment cells | [ |
| kctd15 | attenuate canonical Wnt/Ctnnb1 signaling | MO, mRNA injection | LOF | cranial | zebrafish | defective NC induction (Sox10, Foxd3), increased pigmentation, loss of jaw elements | [ |
| expression constructs | GOF | cranial, trunk | zebrafish | increased NC induction (Foxd3, Sox10), loss of pigmentation, small head | [ | ||
| Krm2 | promotes Lrp6-mediated Wnt signaling in the absence of Dkks | MO, RNA microinjection | LOF, GOF | cranial |
| diminished (LOF) NC markers, ectopic NC-derived structures (GOF) | [ |
| Lrp6 | Wnt co-receptor | normal and mutant RNA injection | GOF, LOF | cranial |
| induced (GOF) or diminished (LOF) NC specifier Snai2 | [ |
| Mark2 (Par-1) | bind to Dvl and regulated by Wnt5a/Wnt11 | MO, mRNA injection | LOF | cranial |
| repressed (LOF) or enhanced NC specification (Sox8, Foxd3, Snai2) | [ |
| Rap2 | stabilizes Lrp6 through TNIK kinase | MO, siRNA | LOF | cranial |
| abrogate ectopic expression of NC markers Snai, Foxd3 | [ |
| retinoic acid | regulate Wnt1 and Wnt3a expression | vitamin A deficiency | LOF | trunk | quail | defective NPB (Pax7) and NC induction (Snai2 and Sox9) | [ |
| Rgs2 | regulates Wnt-Ppard-Sox10 signaling cascade | MO, dominant negative rgs2 construct | LOF | cranial | zebrafish | increased NC induction (Sox10, Snail1b), reduced cranial cartilage formation | [ |
| RhoV | downstream effector of canonical Wnt signaling | MO | LOF | cranial |
| defective NC induction (Sox9, Sox10, Snai), abnormal craniofacial skeletons | [ |
| Ror2 | co-receptor in non-canonical Wnt/PCP signaling | MO | LOF | cranial |
| defective NPB induction (Gbx2, Zic1, Msx1, Msx2), decreased BMP signaling at NPB | [ |
| Skip | a potential scaffold in Ctnnb1/Tcf transcriptional regulation | MO, siRNA | LOF | cranial |
| defective NC induction (Snai2, Sox3, Foxd3), loss of pigment cells | [ |
| Sp5 | downstream effector of canonical Wnt and Fgf pathways | MO | LOF | cranial |
| defective NPB induction (Msx1, Pax3); defects in craniofacial cartilage and pigmentation | [ |
| Tcf7l1 | transcription factor | cKO by AP2α-Cre | LOF | cranial | mouse | anteriorly expanded NC specifiers (Foxd3, Sox9, Sox10, Pax3); exencephaly | [ |
| inhibitory mutants | LOF | cranial |
| defective NPB induction (Msx1) | [ | ||
| THVGR (hormone-inducible Tcf7l1) | GOF | cranial |
| increased NC induction (Snai2, Twist) | [ | ||
| Wnt1 | ligand, canonical pathway | dominant negative Wnt1 | LOF | trunk | chick | repressed NC induction (Snai2) | [ |
| Wnt1 expressing cells | GOF | trunk | chick | inhibited NC induction | [ | ||
| Wnt1/Wnt3a | ligand, canonical pathway | RNA and DNA Injections | GOF | cranial |
| increased NC induction (Krox20, Ap2, Snai2) | [ |
| Wnt1 and/or Wnt3a knockouts | LOF | cranial, trunk | mouse | defective NPB induction (Pax3), cranial skeletons, cranial ganglia | [ | ||
| Wnt5a | ligand, non-canonical pathway | MO, dominant negative, RNA injection | LOF, GOF | cranial |
| defective (LOF) or enhanced (GOF) NC specification (Pax3, Foxd3, Sox8) | [ |
| Wnt6 | ligand, upstream of Dvl-Rho-JNK in PCP signaling | Wnt6 cell implantation, siRNA, | GOF, LOF | trunk | chick | induced (GOF) or diminished (LOF) NC induction | [ |
| Wnt7b | ligand | RNA microinjection | GOF | cranial |
| increased NC induction (Snai2, Twist) | [ |
| Wnt8 | ligand, canonical pathway, downstream of Fgf8a | MO, mRNA injection | LOF, GOF | cranial |
| defective (LOF) NPB induction (Pax3, Sox8), rescued (GOF) NC in Fgf8a-deficient embryos | [ |
| dominant negative, RNA microinjection | LOF, GOF | cranial |
| defective (LOF) or increased (GOF) NC induction (Snai2) | [ | ||
| Wnt11 | ligand, non-canonical pathway | MO, dominant negative, RNA injection | LOF | cranial |
| defective (LOF) or enhanced (GOF) NC specification (Pax3, Foxd3, Sox8) | [ |
| Wnt11r | ligand, non-canonical pathway | MO | LOF | cranial |
| defective NC specification (Foxd3, Sox8) | [ |
Figure 4Bmp/Wnt signaling regulates trunk neural crest cell delamination. Undefined factors from somites inhibit Noggin (purple) expression anteriorly, creating a gradient Bmp (green) activity with a high level in anterior and low level in posterior of the dorsal neural tube. Bmp4, Yap, and RA signaling induce canonical Wnt1 expression, leading to Cyclin D1 transcription and G1/S transition to promote NC cell emigration. However, at the segmental plate mesoderm at the posterior region, Fgf signaling maintains high levels of Noggin that inhibits Bmp activity. Low Bmp activity blocks Wnt signaling, which prevents NC cell delamination from the caudal neural tube.
Experimental findings of Wnt signaling molecules, modulators, and effectors in vertebrate neural crest delamination and migration. (cKO, conditional knockout; EMT, epithelial-mesenchymal transition; GOF, gain of function; KO, knockout; LOF, loss of function; MO; morpholino).
| Molecule | Role in Wnt Signaling | Experimental Approach | Function | Region | Species | Phenotype | Reference |
|---|---|---|---|---|---|---|---|
| ADAM13 | regulated by Gsk3 and Plk | MO | LOF | cranial |
| inhibited NC migration | [ |
| Bmp4 | stimulate Wnt1 expression | BMP4-coated microbeads | GOF | trunk | chick, quail | promoted G1/S transition and NC delamination | [ |
| Cdh2 | cleaved product CTF2 induces Ctnnb1 expression | expression vectors | GOF | trunk | quail | enhanced NC delamination | [ |
| KO | LOF | cardiac | mouse | elevated NC proliferation and reduced NC migration | [ | ||
| Cnn2 | downstream PCP signaling, actin dynamics | MO | LOF | cranial | chick, | inhibited NC migration and reduced cartilage | [ |
| Ctnnb1 | coactivator for Tcf/Lef1 transcription factor | overexpression | GOF | trunk | chick | rescued NC delamination in Noggin-treated neural tubes | [ |
| Dact1 | repress Ctnnb1 as the transcriptional coactivator | MO, expression vectors | LOF, GOF | cranial |
| blocked (LOF) or enhanced (GOF) NC delamination | [ |
| Dact2 | repress Ctnnb1 as the transcriptional coactivator | RNAi, expression vectors | LOF, GOF | truck | chick | blocked (LOF) or enhanced (GOF) NC delamination | [ |
| Dmxl2 (Rbc3a) | regulate Fzd7 endocytosis and enhance Wnt signaling | MO | LOF | cranial, trunk | zebrafish | defective NC migration, cardiac edema, reduced melanocytes | [ |
| Draxin | repress Wnt signaling via Lrp5, modulate laminin | MO, CRISPR; expression vectors | LOF, GOF | cranial | chick | premature NC delamination (LOF), inhibited EMT (GOF) | [ |
| Dvl (Dsh) | PCP signaling | PCP mutants (Dsh-DN, Dsh-DEP+) | LOF | cranial |
| repressed NC migration | [ |
| Efhc1 (Efhc1b) | downregulate Wnt8a | MO | LOF | cranial |
| upregulated Wnt signaling and defective NC migration | [ |
| Fgf8/4 | inhibit Wnt1 expression | Fgf8/4-soaked beads | GOF | trunk | chick | repressed NC emigration or delamination | [ |
| Fgfr1 | inhibit Wnt1 expression | dominant-negative, inhibitor | LOF | trunk | chick | premature NC emigration | [ |
| Gsk3 | phosphorylation and degradation of Ctnnb1 | Gsk3 inhibitors LiCl, BIO | Wnt GOF | trunk, cranial | chick, | inhibited NC delamination and migration | [ |
| Lef1 | transcription factor, canonical pathway | inducible Lef1-GR | GOF | cranial |
| repressed NC migration | [ |
| Lrp5 | co-receptor | MO, CRISPR | LOF | cranial | zebrafish | defective NC migration, cranial skeleton malformation | [ |
| Musk | downstream of non-canonical Wnt11r-Dsh signaling | transgenic fish, KO mouse | LOF | trunk | zebrafish, mouse | defective segmental NC migration | [ |
| Noggin | inhibit Wnt1 expression | CHO-Noggin cells | LOF | trunk | Chick | inhibited G1/S transition and NC delamination | [ |
| Ovo1 | Wnt target, regulate intracellular trafficking of Cdh2 | MO | LOF | cranial | zebrafish | defective migration of NC-derived pigment precursors | [ |
| Pes1 (Pescadillo) | downstream of Wnt4/Fzd3 | MO | LOF | cranial |
| increased apoptosis; defective NC migration, eye and craniofacial cartilage | [ |
| Ptk7 | co-receptor, interact with Ror2 in Wnt/PCP signaling | MO | LOF | cranial |
| defective NC migration | [ |
| required for Fzd7-mediated Dsh localization | MO | LOF | cranial |
| defective NC migration | [ | |
| Rara | regulate Wnt1/Wnt3a expression | dominant negative/active RA receptors | LOF, GOF | trunk | chick | diminished (LOF) or enhanced (GOF) NC emigration | [ |
| RhoA, RhoB | regulated by Wnt6 [ | dominant-negative, inhibitor, activator | LOF, GOF | trunk | chick | enhanced (LOF) or repressed (GOF) NC EMT/delamination | [ |
| RhoU | activated by Wnt1 [ | mutant construct, MO, RNA injection | LOF, GOF | cranial | chick, | blocked (LOF) or impaired NC migration, reduced cartilages | [ |
| Ror2 | co-receptor, interact with Ptk in Wnt/PCP signaling | expression vector | GOF | cranial |
| rescued migration defect in Ptk7-deficient NC cells | [ |
| Sfrp (Fz4-v1) | secreted splice variant of fz4 receptor | MO, mRNA injection | LOF, GOF | cranial, trunk |
| defective NC migration (LOF), altered Wnt signaling | [ |
| Sox9 | phosphorylated by Wnt1 and Bmp signaling | MO; point mutations | LOF | trunk | chick | failed to initiate NC delamination | [ |
| Syn4 (Syndecan4) | interact with Wnt5/Dvl/PCP signaling | MO | LOF | trunk | diminished NC migration, reduced cartilage and melanocytes | [ | |
| Tcf7l1 (Tcf3) | transcription factor, canonical pathway | inducible Tcf3-VP16-GR, Tcf3ΔC-GR | GOF, LOF | cranial |
| impaired NC migration | [ |
| Vgll3 | induce Wnt5a and Wnt8b expression | MO, mRNA injection | LOF, GOF | cranial |
| impaired NC migration, trigeminal and profundal placodes | [ |
| Wnt1 | ligand, canonical pathway | Wnt1 producing cells | GOF | trunk | chick | inhibited NC delamination and migration | [ |
| Wnt1 DNA electroporation | GOF | trunk | chick | enhanced NC delamination | [ | ||
| Wnt3a | ligand, canonical pathway | Wnt3a cells, melanoma cells | GOF | trunk | chick, human cell line | enhanced EMT and NC migration | [ |
| Wnt5 | ligand, PCP signaling | MO | LOF | trunk |
| defective NC migration | [ |
| Wnt11 | ligand, PCP signaling | expression vectors | LOF, GOF | cranial |
| inhibited NC migration | [ |
| Wnt11r | ligand | MO, mRNA injection | LOF, GOF | cranial |
| repressed or rescued NC migrating | [ |
| Yap (Yap1) | bidirectional crosstalk with Wnt and Bmp signaling | expression vectors, mutants, siRNA | GOF, LOF | trunk | chick, quail | stimulated (GOF) or inhibited (LOF) NC EMT and emigration | [ |
Figure 5The role of Wnt signaling in CIL (contact inhibition of locomotion)-mediated directional migration of neural crest cells. Cell-cell interaction between NC cells localizes and activates Dsh (Dvl) at the cell membrane of the contact point, activating the small GTPase RhoA. The activation of RhoA is at least partly regulated by non-canonical Wnt signaling. RhoA inhibits Rac activity at the trailing edge of the cell, restricting a maximal Rac activation at the leading edge (green). Rac stimulates branched actin polymerization and drives the directed migration of NC cells.
Experimental findings of Wnt signaling molecules, modulators, and effectors in vertebrate neural crest proliferation and differentiation. (ca, conditional active; cKO, conditional knockout; GOF, gain of function; KO, knockout; LOF, loss of function; MO; morpholino).
| Molecule | Role in Wnt Signaling | Experimental Approach | Function | Region | Species | Phenotype | Reference |
|---|---|---|---|---|---|---|---|
| Axin2 | scaffold protein for Ctnnb1 degradation | KO | LOF | cranial | mouse | enhanced osteogenic potential and regeneration of NC-derived frontal bone | [ |
| Bmp2 | crosstalk with Wnt/Ctnnb1 signaling | protein to NC culture | GOF | truck | mouse | suppressed sensory neurogenesis of early NC stem cells | [ |
| repress Wnt antagonists Dkk1 and Sost | cKO by Wnt1-Cre | LOF | tooth | mouse | early tooth mineralization defects | [ | |
| Bmp4 | repress Wnt antagonists Dkk2 and Sfrp2 | cKO by Wnt1-Cre | LOF | tooth | mouse | bud-stage arrest of the mandibular molar tooth germs | [ |
| Chd7 | chromatin remodeler, activated by Wnt/Bmp | siRNA, DN, WT expression | LOF, GOF | trunk, DRG | mouse | inhibited (LOF) or maintained (GOF) undifferentiated state (Sox10, p75) of NCSC | [ |
| Ctnnb1 | coactivator for Tcf/Lef1 transcription factor | mRNA injection | GOF | cranial | zebrafish | promoted pigment and cartilage fates from NC cells | [ |
| ca by Wnt1-Cre in premigratory NC cells | GOF | trunk | mouse | suppressed melanocyte (Dct, Mitf) differentiation from premigratory NC cells | [ | ||
| ca by Sox10-Cre in migratory NC cells | GOF | trunk | mouse | ectopic melanocytes, inhibited other lineages from migratory NC cells | [ | ||
| cKO by Wnt1-cre | LOF | trunk | mouse | lack melanocytes and dorsal root ganglia | [ | ||
| ca, cKO by Wnt1-Cre | GOF, LOF | trunk, cranial | mouse | promoted (GOF) or blocked (LOF) sensory neurogenesis of NC stem cells | [ | ||
| cKO by PdgfraCreErt2, Dermo1Cre | LOF | cranial | mouse | forebrain meningeal hypoplasia derived from NC cells | [ | ||
| Wnt1-Cre | LOF | cranial | mouse | defective maintenance of Pitx2 expression in NC cells and abnormal eyes | [ | ||
| Wnt1-cre | LOF | cranial | mouse | affected NC survival and differentiation; failure of craniofacial development | [ | ||
| let-7 miRNA | repressed by Wnt/Lin28a | electroporation of let-7 mimic | GOF | trunk | chick | down-regulation of NC multipotency, promoted differentiation | [ |
| Lin28a | activated by Wnt | siRNA; MO; CRISPR | LOF | trunk | chick | suppressed NC multipotency (Sox10, Foxd3) | [ |
| Msx1 | repress Dkk2 and Sfrp2, interact Bmp4 | KO | LOF | tooth | mouse | bud-stage arrest of the mandibular molar tooth germs | [ |
| Osr2 | upregulate Dkk2 and Sfrp2 expression | KO | LOF | tooth | mouse | supernumerary teeth | [ |
| Prmt1 | inhibit Wnt, Bmp and other signaling | cKO by Wnt1-Cre | LOF | cranial | mouse | decreased mesenchymal proliferation, cleft palate, craniofacial anomalies | [ |
| Tcf7l1 (Tcf3) | transcription factor of Wnt/Ctnnb1 signaling | mutant mRNA injection | LOF | cranial | zebrafish | promoted neural fates, repressed pigment cells | [ |
| Wnt1 | ligand, Ctnnb1-dependent | Wnt1-expressing fibroblasts | GOF | trunk | mouse | promoted sensory neurogenesis of early NC stem cells | [ |
| Wnt1 and Bmp2 | ligands | Wnt1 cell and Bmp2 protein | GOF | truck | mouse | repressed neurogenesis and maintained multipotency of NC stem cells | [ |
| Wnt3a and Bmp2 | ligands | proteins to NC culture | GOF | trunk, DRG | mouse | maintained multipotency (Sox10 or p75) of NC stem cells | [ |
| Wnt inhibitors | stabilize or elevate Axin | XAV939, IWR1 | LOF | cranial |
| repressed NC differentiation and defective cartilage | [ |